MARKET

OLMA

OLMA

Olema Pharmaceuticals, Inc.
NASDAQ
30.85
-1.76
-5.38%
Opening 15:48 12/18 EST
OPEN
32.98
PREV CLOSE
32.60
HIGH
33.11
LOW
30.47
VOLUME
1.74M
TURNOVER
--
52 WEEK HIGH
36.26
52 WEEK LOW
2.860
MARKET CAP
2.43B
P/E (TTM)
-17.0849
1D
5D
1M
3M
1Y
5Y
1D
Olema Oncology rises 6.2%
TipRanks · 3d ago
Kyverna Therapeutics, Immunome, Almonty Industries And Other Big Stocks Moving Higher On Monday
Benzinga · 3d ago
Weekly Report: what happened at OLMA last week (1208-1212)?
Weekly Report · 3d ago
J.P. Morgan Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)
TipRanks · 4d ago
Largest borrow rate increases among liquid names
TipRanks · 6d ago
Olema Pharmaceuticals Is Maintained at Buy by Citigroup
Dow Jones · 6d ago
Olema Pharmaceuticals Price Target Raised to $60.00/Share From $21.00 by Citigroup
Dow Jones · 6d ago
Citigroup Maintains Buy on Olema Pharmaceuticals, Raises Price Target to $60
Benzinga · 6d ago
More
About OLMA
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It is advancing a pipeline of novel therapies by leveraging its deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Its lead product candidate, palazestrant (OP-1250), is a proprietary, orally available complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD), in a Phase 3 clinical trial called OPERA-01. It is being investigated in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. In addition, it is developing OP-3136, a potent KAT6 inhibitor, in a Phase 1 clinical trial. OP-3136 is a novel, orally available small molecule that potently and selectively inhibits KAT6.

Webull offers Olema Pharmaceuticals Inc stock information, including NASDAQ: OLMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OLMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OLMA stock methods without spending real money on the virtual paper trading platform.